logo
Select company
Select metric
$ 9.74MShareholders Equity
VS
Market
20
Sector
30
Industry
33
History
100
$ 1.84Close
$ 1.53 - $ 2.27 52-Week Range
Ticker Information

Ticker

APUS

Company Name

APIMEDS PHARMACEUTICALS US INC

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NYSEMKT

APIMEDS PHARMACEUTICALS US INC - Shareholders Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

APUS - Equity Historical data
DateShareholders Equity
6/30/2025$ 9.74M
3/31/2025$ -1.76M
12/31/2024$ -1.36M
9/30/2024$ -1.05M
6/30/2024$ -713.97K
12/31/2023$ 31.87K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Shareholders Equity

[Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.

APUS - Shareholders Equity, Last 5 years

$ -1.76M

Minimum

Mar 31, 2025

$ 9.74M

Maximum

Jun 30, 2025

$ 815.08K

Average

$ -880.23K

Median

Equity Benchmark Analysis

The chart above depicts the distribution of Equity for companies in the Total Stock Market. The average Equity of the companies is $ 384M with a standard deviation of $ 548.41M.
The following table provides additional summary stats:
Equity in the Market:
filtered constituents3.47K
min$ -1.4B
max$ 2.14B
average$ 384M
median$ 165.72M
std$ 548.41M